Angiosarcoma of the breast after quadrantectomy and postoperative radiotherapy for carcinoma

Angiosarcoma of the breast (AB) is a rare entity: its overall incidence is estimated at between 0.002% and 0.005% per year. Some potential risk factors have been described, mainly previous irradiation of the breast. We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Angiosarcoma of the breast after quadrantectomy and postoperative radiotherapy for carcinoma

Cited by 9 publications

References 7 publications

Primary and secondary angiosarcoma of the breast: The Mayo Clinic experience

Primary and secondary angiosarcoma of the breast: The Mayo Clinic experience

Large aplasia cutis congenita of the vertex conservative management

Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature

Contact Info

Product

Resources

About